Related references
Note: Only part of the references are listed.Downregulation of microRNA-324-3p inhibits lung cancer by blocking the NCAM1-MAPK axis through ALX4
Tieniu Song et al.
CANCER GENE THERAPY (2021)
Suppressing microRNA-29c promotes biliary atresia-related fibrosis by targeting DNMT3A and DNMT3B
Jian-yao Wang et al.
CELLULAR & MOLECULAR BIOLOGY LETTERS (2019)
Antitumor activity of CD56-chimeric antigen receptor T cells in neuroblastoma and SCLC models
Denise L. Crossland et al.
ONCOGENE (2018)
The biology and management of non-small cell lung cancer
Roy S. Herbst et al.
NATURE (2018)
miRNA-148a serves as a prognostic factor and suppresses migration and invasion through Wnt1 in non-small cell lung cancer
Yong Chen et al.
PLOS ONE (2017)
Tumor flare after start of RAF inhibition in KRAS mutated NSCLC: A case report
Wouter W. Mellema et al.
LUNG CANCER (2015)
Expression of miR-148/152 Family as Potential Biomarkers in Non-Small-Cell Lung Cancer
Ying-zhi Qin
MEDICAL SCIENCE MONITOR (2015)
MicroRNA-152 targets ADAM17 to suppress NSCLC progression
Yunshu Su et al.
FEBS LETTERS (2014)
MiR-152 and miR-185 co-contribute to ovarian cancer cells cisplatin sensitivity by targeting DNMT1 directly: a novel epigenetic therapy independent of decitabine
Y. Xiang et al.
ONCOGENE (2014)
MiR-152 suppresses the proliferation and invasion of NSCLC cells by inhibiting FGF2
Zhenshun Cheng et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2014)
miR-29 Acts as a Decoy in Sarcomas to Protect the Tumor Suppressor A20 mRNA from Degradation by HuR
Mumtaz Yaseen Balkhi et al.
SCIENCE SIGNALING (2013)
The next level of complexity: post-transcriptional regulation by microRNAs
Rafael Kramann et al.
KIDNEY INTERNATIONAL (2011)
Polysialic Acid Neural Cell Adhesion Molecule (PSA-NCAM) is an adverse prognosis factor in glioblastoma, and regulates olig2 expression in glioma cell lines
Marie-Claude Amoureux et al.
BMC CANCER (2010)
Altered Expression of MiR-148a and MiR-152 in Gastrointestinal Cancers and Its Clinical Significance
Yue Chen et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2010)
Alteration of DNA methyltransferases contributes to 5′CpG methylation and poor prognosis in lung cancer
Ruo-Kai Lin et al.
LUNG CANCER (2007)
4-year mortality in patients with non-small-cell lung cancer: Development and validation of a prognostic index
Francois Blanchon et al.
LANCET ONCOLOGY (2006)
Elevated mRNA levels of DNA methyltransferase-1 as an independent prognostic factor in primary nonsmall cell lung cancer
Hojoong Kim et al.
CANCER (2006)
MicroRNAs: Genomics, biogenesis, mechanism, and function
DP Bartel
CELL (2004)
DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells
MF Robert et al.
NATURE GENETICS (2003)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
DNA methylation, methyltransferases, and cancer
KD Robertson
ONCOGENE (2001)
Share Paper
